Key terms
About CAMP
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CAMP news
Yesterday
6:51am ET
Analysts’ Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)
Nov 21
4:16pm ET
Camp4 Therapeutics reports Q3 EPS ($24.19) vs.($29.21) last year
Nov 05
6:21am ET
Camp4 Therapeutics initiated with an Outperform at William Blair
Nov 05
6:20am ET
Camp4 Therapeutics initiated with an Outperform at Leerink
Nov 05
4:55am ET
Camp4 Therapeutics initiated with an Overweight at JPMorgan
Nov 05
4:50am ET
Camp4 Therapeutics initiated with an Overweight at Piper Sandler
Nov 03
6:30am ET
Opening Day: Polyrizon, Gelteq debut in quiet IPO week
No recent press releases are available for CAMP
CAMP Financials
Key terms
Ad Feedback
CAMP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CAMP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range